The role of M&A in the pharmaceutical sector: a driver of scientific progress or an alternative to human capital?

Federici, Giorgio (A.A. 2024/2025) The role of M&A in the pharmaceutical sector: a driver of scientific progress or an alternative to human capital? Tesi di Laurea in Advanced corporate finance, Luiss Guido Carli, relatore Pierluigi Murro, pp. 60. [Master's Degree Thesis]

[img] PDF (Full text)
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract/Index

M&A trend. Definition and classification of M&A transactions. M&A in the pharmaceutical sector. Latest important deals. R&D as the main driver of scientific innovation. Historical analysis of R&D expenditure in big pharma. Big pharma: the top companies by revenue and research spending. Historical analysis of R&D and M&A investments by the top 9 pharmaceutical companies over the last 5 years. Historical analysis. Overall comparison between companies.

References

Bibliografia e sitografia: pp. 58-60.

Thesis Type: Master's Degree Thesis
Institution: Luiss Guido Carli
Degree Program: Master's Degree Programs > Master's Degree program in Corporate Finance, English language (LM-77)
Chair: Advanced corporate finance
Thesis Supervisor: Murro, Pierluigi
Thesis Co-Supervisor: Santella, Rosella
Academic Year: 2024/2025
Session: Autumn
Deposited by: Alessandro Perfetti
Date Deposited: 03 Mar 2026 07:31
Last Modified: 03 Mar 2026 07:31
URI: https://tesi.luiss.it/id/eprint/45019

Downloads

Downloads per month over past year

Repository Staff Only

View Item View Item